Medical Disclaimer

Not medical advice

The content on US Telehealth Review — including reviews, comparison tables, dosing references, peptide profiles, and provider scoring — is provided for general informational purposes only. It is not, and should not be construed as, medical advice, diagnosis, or treatment. The site is not a substitute for professional medical consultation. Readers are urged to consult a licensed clinician before starting, modifying, or stopping any medication, peptide, supplement, lifestyle change, or treatment program.

No doctor-patient relationship

Reading content on this site does not create a doctor-patient relationship between any reader and any author, editor, medical reviewer, or contributor. Our medical reviewer, Alen A. Schwartz MD, reviews editorial content for general clinical accuracy; this review does not constitute personalized medical advice to any individual reader.

Compounded GLP-1 medications

Some providers covered on this site dispense compounded semaglutide and compounded tirzepatide, which are not FDA-approved as finished drug products. Compounded medications are prepared by state-licensed pharmacies for individual patients pursuant to a valid prescription. Compounded products may differ from FDA-approved Ozempic, Wegovy, Mounjaro, or Zepbound in formulation, ingredients, and clinical evidence base. Readers considering compounded medications should review the FDA's April 2026 guidance on GLP-1 compounding and discuss with their prescribing clinician.

Peptide therapies

Many peptides discussed on this site — including BPC-157, TB-500, CJC-1295, Ipamorelin, NAD+, MOTS-c, SS-31, Epithalon, Semax, Selank, Cerebrolysin, Dihexa, P21, Pentadeca Arginate, LL-37, KPV, DSIP, Tesamorelin, MK-677, IGF-1 LR3, GHRP-2, GHRP-6, Hexarelin, PT-141, oxytocin, kisspeptin, gonadorelin, Melanotan II, and others — are not approved by the FDA as finished pharmaceutical drugs for the indications discussed. Some are marketed as "research chemicals" and are not intended for human consumption. Others are compounded by licensed pharmacies. Readers should not interpret editorial coverage as endorsement of off-label or unapproved use. Discussion of mechanism, dosing, and clinical literature is for educational reference only.

Pricing and provider details

Pricing, peptide selection, prescriber roster, and shipping policies shown on this site are accurate as of each page's last-updated date. Providers change these details frequently and without notice to us. Readers should confirm current pricing and program details on the provider's own website before making a purchase decision.

Editorial scores are opinions

Provider scores published on this site are editorial opinions of Ranika Editorial Group LLC's editorial team, based on the v3.0 six-pillar rubric documented on the methodology page. Scores are not endorsements of medical safety, clinical efficacy, or suitability for any individual reader.

Adverse events

If a reader experiences a serious adverse event related to any medication or peptide, the reader should immediately contact their prescribing clinician and, if appropriate, emergency medical services. Adverse events involving FDA-regulated products can also be reported to the FDA MedWatch program at fda.gov/medwatch.

Emergency disclaimer

This site is not a substitute for emergency medical care. If a reader is experiencing a medical emergency, the reader should call 911 (United States) or the local emergency number immediately.

External links

We link to provider websites, FDA pages, scientific publications, and other third-party resources for reader reference. We do not control the content of external sites and are not responsible for the accuracy or safety of information found at those external URLs. Inclusion of an external link is not an endorsement.

Contact

Questions about this disclaimer can be sent to legal@ustelehealthreview.com.